NuProbe

NuProbe

Biotechnology Research

Houston, Texas 5,200 followers

Focused Genomics Panels

About us

NuProbe prototypes and validates high-sensitivity genomics panels for difficult DNA biomarkers including CNVs, gene fusions, and low-frequency mutations.

Website
https://www.nuprobe.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Houston, Texas
Type
Privately Held
Founded
2016
Specialties
molecular diagnostics, sequencing, PCR, and NGS

Locations

Employees at NuProbe

Updates

  • View organization page for NuProbe, graphic

    5,200 followers

    Gilead recently conducted a clinical trial for GS-3583, an FMS-like tyrosine kinase 3 (FLT3) agonist Fc fusion protein. Gilead collaborated with NuProbe to develop a qBDA panel that targeted multiple AML hotspot mutations. This qBDA panel significantly helped in the accurate and sensitive detection of drug-induced mutation emergence down to 0.06% variants allele frequency with minimal sequencing depth, offering more information for the trial’s efficacy evaluation. Gilead discovered that other NGS methods were unable to detect what NuProbe's innovative qBDA technology detected. NuProbe’s qBDA technology enhances the precision and effectiveness of cancer therapy research and development.   Learn more about Gilead’s clinical trial published in the AACR Editor’s Picks here: https://lnkd.in/gngWUVVX

    • No alternative text description for this image
  • View organization page for NuProbe, graphic

    5,200 followers

    🚀 Exciting News from NuProbe Explorations! 🚀 Are you an early-stage startup in the molecular diagnostics and medical devices field? Searching for a state-of-the-art lab and office space in Houston, TX? Look no further! We are thrilled to introduce NuProbe Explorations, an innovative accelerator dedicated to fostering the growth of startups in the life sciences sector. 🧬 📍 Located in the heart of the thriving Kirby Interchange Life Science Park at 8955 Interchange Drive, Houston, NuProbe Explorations is your go-to destination for cutting-edge lab and office spaces. 🏢 Here's why you should consider joining our vibrant community: ✅Expanding Space: NuProbe Explorations is expanding to accommodate your growing needs. With a total of 17,000 sq. ft. of space, including 4,500 sq. ft. of ready space, we offer private, semi-private, and shared office and lab spaces that are perfect for your unique requirements. 🧪💼 ✅ Houston's Life Science Hub: Located in a prime life science hub, you'll be at the epicenter of innovation in Houston, with easy access to resources, partners, and potential investors. 🌆 Whether you're a startup looking to scale or a researcher with groundbreaking ideas, NuProbe Explorations is the place to turn your vision into reality. Ready to explore the possibilities? Contact us today to learn more about our available spaces and how we can support your journey. 📩 Don't miss out on this incredible opportunity to be part of something exceptional! Join NuProbe Explorations and embark on a path of innovation, growth, and success. 🌟 #NuProbeExplorations #HoustonStartups #MolecularDiagnostics #MedicalDevices #InnovationHub #LabSpace #OfficeSpace #HoustonLifeScience https://www.nuprobexp.com

    NuProbe Explorations: Accelerate your biotech startup

    NuProbe Explorations: Accelerate your biotech startup

    nuprobexp.com

  • NuProbe reposted this

    View organization page for NuProbe, graphic

    5,200 followers

    Achieve increased sensitivity for detecting and monitoring DNA mutations, gene fusions, and copy number alterations with a custom oncology research assay. Work with our team to define a bespoke assay that allows ultrasensitive detection for heme malignancy or solid tumor research. Learn about our development services for biopharma and research applications at https://lnkd.in/geaY7vNP Want to review a recent proof of concept custom assay? Check out a retrospective study where a custom heme panel detected NPM1 mutations below 0.01% VAF for research focused on MRD in AML clinical samples. https://lnkd.in/guz-eEyq #MRD #NGS #SolidTumor #Genomics #Fusions #Oncology #CancerResearch #cfDNA

    • No alternative text description for this image
  • NuProbe reposted this

Similar pages

Browse jobs

Funding